Online Program

Illicit Tobacco Trade: Lessons from a National Research Council (NRC) and Institute of Medicine (IOM) Report

Wednesday, November 4, 2015

Peter Reuter, School of Public Policy and Department of Criminology, University of Maryland, College Park, MD
Malay Majmundar, Division of Behavioral and Social Sciences and Education, National Research Council, Washington, DC
Frank J. Chaloupka, PhD, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL
This session will focus on the soon-to-be-released National Research Council (NRC) and Institute of Medicine (IOM) report, Understanding the U.S. Illicit Tobacco Market: Characteristics, Policy Context, and Lessons from the International Experience.  Key topics include the volume of the illicit trade; the structure of illicit markets, including supply and demand determinants; the impact of various policy actions on illicit markets; the effectiveness of interventions against the illicit tobacco trade; the applicability of international experiences to the illicit tobacco market in the United States; and recommendations relating to the strengths and weaknesses of currently available data and research.

Learning Areas:

Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe the nature and structure of existing illicit tobacco markets. Differentiate between U.S. and international illicit markets. Evaluate the potential impact of various policy actions on the illicit market. Identify critical gaps in data collection and research.

Keyword(s): Tobacco Control

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been researching the economics of tobacco and tobacco control for nearly 30 years. As part of this, I have conducted extensive research on the measurement and determinants of illicit tobacco trade and on the impact of measures to curb illicit trade. I was a member of the committee that produced the NAS/IOM report that is the subject of this poster.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.